直 Japanese PDF Font
  • 弁護士等
  • 業務内容
  • 論文等
  • オフィス
  • 事務所概要
  • 採用情報
Finnegan
  • 最新情報
  • Finneganについて
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • プロボノ活動
  • 事務所運営管理
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

PTAB Shifts 'Midstream,' Puts Unusual End to CBM Review

November 16, 2016

Law360

On November 15, 2016 the Patent Trial and Appeal Board (PTAB) ruled in favor of Finnegan client Securus Technologies, abruptly ending its covered business method (CBM) proceeding after determining that the patent did not relate to a financial product.

Global Tel*Link Corp. and Securus compete in the prison telecommunications space. In May 2015, Global Tel*Link Corp. petitioned for a CBM review of a Securus patent related to call-processing and call-billing technology in used in correctional facilities. From the beginning, Securus argued that the patent was not appropriate for CBM review, as CBM reviews are limited to patents used in financial products or services, and there was no language in any of the patent’s claims that were financial in nature. The PTAB initially disagreed and proceeded with the CBM review, but upon further consideration of the claims, they concluded that the patent did not relate to a financial service.

Tags

telecommunications

Related Practices

特許庁における無効審判

PTABにおける無効手続:当事者系レビューおよび特許付与後レビュー

Related Industries

Electrical and Computer Technology

金融サービス・ビジネスシステム

Related News

Award/Ranking

Forbes Names Finnegan Partner Erika Harmon Arner on its Inaugural 2026 America’s Top Women Lawyers List

June 5, 2026

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Commentary

Quince Aims to Have ‘Dupe’ Evidence Shape Ugg Shoe Patent Trial

May 26, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Award/Ranking

Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey

May 7, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Award/Ranking

Finnegan Wins IP Firm of the Year at the 2026 LSPN Awards

May 1, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • プライバシー
  • 免責事項
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP